What to Look for in a Terpene COA: A Practitioner's Reading Guide

A certificate of analysis is referenced constantly in cannabis operations. Operators ask for them. Compliance officers file them. Sales reps send them. But there is a gap between requesting a COA and actually reading one — understanding what every section means, what numbers are acceptable, what results signal a problem, and what questions the document should raise before you use the product.

For terpene infusion specifically, this gap has real consequences. In vapor-phase infusion, the terpene product is volatilized and driven into the flower matrix under vacuum. There is no subsequent processing step that filters contaminants or neutralizes residuals. What is in the terpene product is in the finished flower. The COA is the primary tool that gives you visibility into what you are actually infusing.

This guide is a field reference. It walks through each section of a terpene COA, explains what each field is measuring and why it matters, describes what acceptable results look like, and identifies the red flags that should stop a purchase decision or an infusion cycle. It also covers the questions to ask your supplier when the COA raises issues or when important sections are missing.

This is US general educational content. Laboratory accreditation requirements, acceptable limits for specific contaminants, and COA content requirements vary by state and by regulatory context. Verify the applicable standards in your jurisdiction before establishing acceptance criteria for your operation.

What a terpene COA is — and what it is not

A certificate of analysis is a document issued by a laboratory that reports the results of testing performed on a specific sample of a product. For terpenes, this typically means: what compounds are present and at what concentrations, and whether the product meets specified limits for various contaminants.

What a COA is not is a guarantee. It is a snapshot of a specific sample tested at a specific time. Whether the sample the lab tested is representative of the lot you are purchasing depends on how the sampling was done. Whether the document you are looking at reflects current inventory or archived testing depends on when it was issued. A COA does not tell you what is in the container on your shelf today — it tells you what was in a sample of the product at the time of testing.

This is not a reason to distrust COAs. It is a reason to read them carefully and to know what questions to ask when the document does not tell the full story. The sections that follow explain how to do that.

Section 1: Sample and batch identification

Before reading any test result, verify that the COA corresponds to the product you are evaluating.

What to look for:

• Lot or batch number — should match the lot number on the product you received. If the supplier sends a COA without a lot number, or sends a generic COA that applies to a "product line" rather than a specific batch, this is a red flag. Terpene quality can vary between batches; a lot-specific COA is the minimum standard for a serious supply relationship.
• Sample receipt date and report date — tells you when the sample was tested. For volatile compounds like terpenes, recency matters. A COA issued 18 months ago for a product with a 12-month shelf life tells you little about what you are receiving today.
• Sample description — should match the product you ordered (same product name, same SKU, same source category — CDT, botanical, or synthetic). Mismatches here are either administrative errors or a signal that the supplier is reusing COAs across products that were not all individually tested.
• Laboratory name and accreditation number — the testing laboratory should be a third-party facility, not the supplier's in-house lab. Look for ISO 17025 accreditation or equivalent state-recognized accreditation. If the COA is from the supplier's own quality control department, it is not an independent test.

The question to ask: "Can you confirm that this COA is batch-specific and corresponds to the lot number on the product I received?"

Section 2: Terpene identity and purity panel

This is the core section of a terpene COA — the data on what compounds are present and at what concentrations. For terpene products, this panel serves two functions: it verifies that the product contains what the supplier claims, and it shows the full compound profile including components the supplier may not have highlighted.

What to look for:

• Named compound match — the dominant terpenes listed on the COA should match what the supplier's label or specification sheet claims. If you purchased a limonene-dominant blend and the COA shows myrcene as the most abundant compound, something is wrong.
• Percentage totals — high-quality isolated terpene products (single compounds) should show the named compound at 95%+ of total content, often higher. For formulated blends, the percentages should match the supplier's stated formula. If a COA shows 60% "terpene mixture" as an undifferentiated entry rather than individual compound percentages, the document is not giving you meaningful quality information.
• Minor compound presence — a full terpene panel will list all detected compounds, not just the dominant ones. For CDT products, the presence of a range of minor terpenes is expected and desirable — it is part of what you are paying for. For botanical single-compound isolates, the presence of unexpected compounds at significant levels warrants an explanation from the supplier.
• Detection threshold notation — compounds present below the laboratory's detection threshold should be listed as "ND" (not detected) or "< [threshold value]." Any result listed as "trace" without a quantified level is ambiguous and worth clarifying.

Red flags:

• A COA that lists only the primary compound and no other detected components is likely using a limited analytical panel. A credible full terpene analysis detects and reports all compounds above threshold, including ones that indicate contamination or adulteration.
• Percentages that do not sum to approximately 100% (for isolated compounds) without an explanation for what the remaining fraction contains.
• A COA that reports a product as "98% pure" without specifying what the other 2% consists of.

The question to ask: "Does this COA reflect a full terpene panel using GC-MS analysis, or a limited panel? Can you share the raw chromatogram data?"

Section 3: Residual solvents

Many terpene extraction processes use solvents — ethanol, hexane, propane, butane, and others depending on the extraction method. Residual solvents are compounds that remain in the finished product after processing. For vapor-phase infusion into flower, residual solvents in your terpene product become residual solvents in your cannabis.

What to look for:

• Full solvent panel — a credible residual solvent test covers the solvents plausibly used in the extraction process. For steam-distilled CDTs, solvent residuals are typically minimal, but the test should still be run. For solvent-extracted products, a full panel covering Class 1 (most hazardous), Class 2, and Class 3 solvents is the standard.
• Reported levels vs. limits — results should be expressed in parts per million (ppm) and should be compared against stated limits. Your state's cannabis testing program may specify acceptable residual solvent limits for cannabis products; a responsible terpene supplier will know these limits and confirm that their products comply.
• ND (not detected) on critical solvents — for Class 1 solvents (benzene, toluene, ethylene oxide, and similar), the acceptable result is ND at the detection limit. Any detectable level of a Class 1 solvent in a terpene product intended for cannabis infusion is a disqualifying finding.

Red flags:

• A COA that omits residual solvent testing entirely — particularly for CDT products or any product produced using solvent-based extraction.
• Levels reported in ranges rather than specific values ("< 500 ppm" without a more precise measurement for a compound at a level approaching that limit).
• A supplier who claims that "steam-distilled" or "CO2-extracted" products do not need solvent testing. Solvent testing is a verification step — the extraction method is the supplier's claim; the COA is the independent confirmation.

The question to ask: "Which solvents are covered in the residual solvent panel, and what are the quantified results for each? What extraction method was used, and why does the panel include or exclude specific solvents?"

Section 4: Heavy metals

Cannabis plant material accumulates heavy metals from soil and growing media through a process called phytoaccumulation. Terpene extraction concentrates the plant material — and potentially concentrates any heavy metals it contains. For cannabis-derived terpenes especially, heavy metal testing is a non-negotiable panel.

What to look for:

• The four required metals — most cannabis regulatory frameworks require testing for lead, arsenic, cadmium, and mercury at minimum. These are the metals most commonly associated with cannabis cultivation risks. A credible COA reports all four.
• Quantified results in ppb — results should be expressed in parts per billion (ppb) and compared against action limits. California, for example, sets action limits for cannabis products that many operators use as a reference standard even in states without explicit limits.
• ND or well below limits — all four metals should be well below any applicable action limit. Heavy metal contamination in terpene products intended for inhalation is a product safety issue, not just a compliance issue.

Red flags:

• A COA that omits heavy metal testing for cannabis-derived terpenes.
• Results that are close to action limits without explanation — an occasional outlier warrants an investigation into the source material before purchasing.
• Botanical terpene suppliers who claim heavy metal testing is unnecessary because the product is plant-derived. Plant origin does not guarantee heavy metal absence; it is exactly why testing is needed.

The question to ask: "What are the source materials for this product, and what is the documented heavy metal testing history across recent lots?"

Section 5: Pesticide residuals

For CDT products extracted from cannabis plant material, pesticides used in cultivation can carry over into the terpene extract. Pesticide residual testing is particularly important for CDTs sourced from cultivators who are not operating under cannabis-specific regulatory frameworks with mandatory pesticide testing.

What to look for:

• Full pesticide panel — the panel should cover organophosphates, pyrethroids, organochlorines, and other pesticide classes relevant to cannabis cultivation in the source region. A full panel runs 50–80+ compounds; a limited panel covering only 10–15 compounds provides much weaker assurance.
• ND on all or near-all compounds — for a product intended for inhalation, the expected result is ND across the panel. Detectable levels of any pesticide compound at concentrations above action limits for the intended use context are disqualifying.
• Comparison to cannabis product limits — if you are infusing terpenes into cannabis that will ultimately be tested as a cannabis product, any pesticide residuals in your terpenes will appear in the finished product test. Know your state's action limits for cannabis products and verify that terpene inputs are well below those levels.

Red flags:

• Pesticide testing omitted from a CDT COA with no explanation.
• A supplier who claims that "licensed cultivator" sourcing eliminates the need for independent pesticide verification. The COA is the verification.
• A botanical terpene supplier who does not provide pesticide testing — botanical source materials are also subject to agricultural pesticide use.

The question to ask: "How many compounds are included in the pesticide panel, and can you provide the full list? What is the sourcing documentation for the cannabis material used in CDT extraction?"

Section 6: Microbiological testing (when applicable)

Microbiological testing — for yeast, mold, E. coli, Salmonella, and similar — is more common in cannabis flower and extract COAs than in terpene COAs, because terpene compounds are generally hostile to microbial survival. However, for CDT products that involve significant handling of fresh plant material during extraction, microbial testing may be appropriate depending on your risk tolerance and regulatory context.

When to require it: If your terpene supplier is processing fresh-frozen cannabis biomass and producing CDTs through a process that involves significant water and plant-material contact, ask whether microbial testing is part of their quality protocol. The risk is low in pure terpene extracts, but the test is not expensive and the documentation is valuable.

When it is not needed: For isolated botanical terpenes at high purity, microbiological testing is not typically expected or necessary.

Section 7: Carrier oil and diluent confirmation

This section is often absent from terpene COAs because it is not a standard panel — it requires the laboratory to specifically test for compounds that should not be present rather than compounds that should. But for vapor-phase flower infusion, carrier-free verification is one of the most important quality attributes of a terpene product.

What to look for:

• Explicit confirmation of absence — a credible supplier will confirm in writing, either on the COA or in a product specification sheet, that the product contains no carrier oils (MCT, fractionated coconut oil, propylene glycol, polyethylene glycol, or similar) and no diluents or additives of any kind.
• GC-MS chromatogram review — a full GC-MS analysis will reveal the presence of fatty acid profiles characteristic of carrier oils if they are present, even if not specifically flagged in the report. An experienced analyst reviewing the chromatogram data can identify carrier contamination that might not be caught by a standard terpene panel.

Red flags:

• A supplier who cannot provide explicit written confirmation that the product is carrier-free.
• A COA that shows a terpene percentage well below what would be expected for a pure product (e.g., a "pure myrcene" product showing 60% myrcene with 40% unlabeled material).
• Any mention of "natural carrier," "added for stability," or "proprietary blend base" in the product description.

The question to ask: "Does this product contain any carrier oils, diluents, or additives? Can you provide written confirmation that the product is carrier-free, and can I see the full GC-MS chromatogram?"

CDT vs. botanical signals in the COA data

One practical use of a full terpene panel COA is to evaluate the plausibility of a supplier's source category claim. A CDT product and a botanical-formulated product can have the same dominant terpene percentages; the minor terpene data is often where they diverge.

CDT signals: A genuine full-spectrum CDT extract from a well-characterized cultivar will show a complex minor terpene profile — multiple compounds at low concentrations that reflect the whole-plant chemistry of the source material. Guaiol, fenchol, alpha-terpinene, borneol, sabinene, and similar compounds appearing at 0.01–0.2% alongside the dominant terpenes are consistent with authentic CDT character. The specific pattern of minor compounds is also often cultivar-identifiable.

Botanical formulation signals: A botanical blend — even a well-formulated one — typically shows a cleaner minor compound profile. The dominant terpenes are present at their labeled percentages; minor terpene content is either absent or limited to a small number of intentionally added compounds. This is not inherently problematic — a high-quality botanical blend designed for infusion is a legitimate product — but it means the COA is inconsistent with a CDT claim. If a supplier is marketing a product as CDT but the COA shows no minor terpene complexity, ask for source documentation.

Building a COA review protocol for your operation

Reading COAs ad hoc is better than not reading them. Having a documented review protocol is better than ad hoc reading. A minimal protocol for terpene inputs in a vapor-phase infusion operation:

1. Confirm lot match — verify the lot number on the COA matches the product received before the document is filed.
2. Check issue date — flag any COA more than 12 months old for supplier follow-up before use.
3. Verify accreditation — confirm the laboratory is third-party and accredited. Note the accreditation number in your supplier file.
4. Review terpene panel — confirm dominant compound percentages match the product specification. Note any unexpected compounds.
5. Check residual solvents — confirm Class 1 solvents are ND. Confirm all reported levels are below applicable limits.
6. Check heavy metals — confirm lead, arsenic, cadmium, and mercury are present and reported well below action limits.
7. Check pesticides — for CDTs, confirm the panel is comprehensive and results are ND or well below limits.
8. Confirm carrier-free — verify written confirmation or review chromatogram for carrier oil signals.
9. Document the review — note who reviewed the COA, when, and the outcome. This becomes part of your batch record for each infusion cycle.

Summary

• A terpene COA is a snapshot of a specific sample — verify lot number, issue date, and laboratory accreditation before reading any results
• The terpene identity and purity panel should show compound percentages that match the product specification; for CDTs, expect minor terpene complexity; for botanicals, expect a cleaner profile
• Residual solvent testing is required for any solvent-extracted product; Class 1 solvents should be ND; a missing solvent panel is a red flag regardless of the claimed extraction method
• Heavy metal testing — lead, arsenic, cadmium, mercury — is non-negotiable for CDTs and best practice for botanical products intended for inhalation
• Pesticide residual testing should cover a comprehensive panel; a limited 10–15 compound panel provides weak assurance for a product being infused into cannabis
• Carrier-free verification is critical for vapor-phase flower infusion; require explicit written confirmation and review the chromatogram data if the product description is ambiguous
• A documented COA review protocol with consistent steps and review records is a quality management asset, not just a compliance exercise

For guidance on evaluating terpene sourcing options and what differentiates CDTs, botanical, and synthetic products for infusion applications, see the cannabis terpene sourcing buyer's guide. For context on how minor terpene complexity in CDT products contributes to full-spectrum aromatic character, see the minor terpenes guide for blenders. To understand how vapor-phase infusion interacts with your terpene inputs, see what vapor-phase infusion is and how it works. To discuss quality documentation requirements for a TheBOX® infusion program, contact the team.